|
gptkbp:instance_of
|
gptkb:hospital
|
|
gptkbp:bfsLayer
|
5
|
|
gptkbp:bfsParent
|
gptkb:Atropine
|
|
gptkbp:appointed_by
|
intramuscular injection
patient or caregiver
|
|
gptkbp:approves
|
gptkb:2000
|
|
gptkbp:associated_with
|
gptkb:Epinephrine
|
|
gptkbp:brand
|
gptkb:Atro_Pen
|
|
gptkbp:clinical_trial
|
Comparative Study with Epi Pen
Efficacy in Anaphylaxis
Safety in Children
|
|
gptkbp:color
|
gptkb:color
|
|
gptkbp:contains
|
epinephrine
|
|
gptkbp:contraindication
|
hypersensitivity to epinephrine
|
|
gptkbp:dosage_form
|
0.15 mg for children
0.3 mg for adults
|
|
gptkbp:formulation
|
auto-injector
|
|
gptkbp:height
|
1 inch
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Atro Pen
|
|
gptkbp:indication
|
severe allergic reactions
|
|
gptkbp:instrument
|
25 gauge
|
|
gptkbp:invention
|
patented
|
|
gptkbp:is_available_in
|
various dosages
|
|
gptkbp:is_monitored_by
|
15 minutes
|
|
gptkbp:is_used_for
|
treating anaphylaxis
|
|
gptkbp:length
|
5.5 inches
0.5 inches
|
|
gptkbp:manufacturer
|
gptkb:Amgen
|
|
gptkbp:marketed_as
|
various brand names
|
|
gptkbp:packaging
|
single-use device
|
|
gptkbp:position
|
lying down
|
|
gptkbp:previous_name
|
gptkb:Company
|
|
gptkbp:regulatory_compliance
|
FDA approved
|
|
gptkbp:release_region
|
gptkb:Australia
gptkb:New_Zealand
gptkb:UK
gptkb:USA
gptkb:Native_American_tribe
|
|
gptkbp:replaced_by
|
gptkb:Auvi-Q
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:safety_features
|
safety cap
|
|
gptkbp:shelf_life
|
18 months
|
|
gptkbp:side_effect
|
gptkb:drug
anxiety
dizziness
headache
nausea
hypertension
tremors
increased heart rate
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:training
|
gptkb:theorem
|
|
gptkbp:website
|
outer thigh
|
|
gptkbp:weight
|
0.5 ounces
|
|
gptkbp:width
|
1.5 inches
|